论文部分内容阅读
Aims: The hematologic malignancy acute promyelocytic leukemia (APL) exhibits a failure of myeloid differentiation.Most patients with APL can be induced to complete remission by all-trans retinoic acid (ATRA) or arsenic trioxide treatment through presumed degradation of the PML-RARα fusion protein.